Michail Ignatiadis, Director, Breast Medical Oncology Clinic and Program at Institut Jules Bordet, shared on LinkedIn:
“Great to be at the International Society of Liquid Biopsy (ISLB) Congress in Madrid!
Liquid biopsy is rapidly transforming precision oncology, from ESR1 mutation monitoring to ctDNA-guided treatment strategies and molecular residual disease detection (MRD).
Always a pleasure to reconnect with good friends and great colleagues Daniel Stover, Christian Rolfo, MD, PhD, MBA,Dr.hc, Umberto Malapelle and Eloisa Jantus
Congratulations to Christian Rolfo, MD, PhD, MBA,Dr.hc and Umberto Malapelle and the entire ISLB team for putting together an excellent scientific meeting.
And many thanks to Menarini for the kind invitation!”
Other articles about International Society of Liquid Biopsy on OncoDaily.